Back to top
more

Vanguard Specialized Portfolios Health Care Fund: (MF: VGHCX)

(NASDAQ Mutual Funds) As of Feb 13, 2026 05:54 PM ET

$207.90 USD

+2.05 (1.00%)

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

1-Strong Buy of 5 1        

View All Zacks Mutual Fund Rank #1's

Latest Performance as of Jan 31, 2026

Total Return %* Percentile Rank Objective
YTD 0.05 53
3 months 8.31 26
6 months 24.13 50
1 Year 11.40 38
3 Year 6.87 59
5 Year 6.33 30
10 Year 8.44 75

* Annual for three years and beyond.

Zacks Premium Research for VGHCX

Zacks MF Rank

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Strong Buy 1
MF Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

% Unrealized Gain 37.78
% Yield NA
% SEC Yield NA
Net Assets (Mil $) 1/31/2026 5,748.80
% Turnover 1/31/2026 29.00

Risk

3 Year 5 Year 10 Year
Beta 0.62 0.57 0.66
Alpha -6.43 -2.99 -1.96
R Squared 0.28 0.39 0.50
Std. Dev. 13.52 13.81 14.02
Sharpe 0.22 0.28 3.00

Sector / Country Weightings

As of 1/31/2026 % of Portfolio
Health 60.68
Other 14.07
Finance 8.54
Retail Trade 3.99
Industrial Cyclical 3.81
Technology 3.72
Services 3.70
Non-Durable 1.49

Portfolio Holdings

Top Equity Holdings
(As of 10/31/2025)
% of Portfolio Value (Mil$)
ELI LILLY & CO 9.62 3,605.36
ASTRAZENECA PLC 5.77 2,162.99
UNITEDHEALTH GROUP INC 4.35 1,630.01
MERCK & CO INC 4.15 1,556.81
VERTEX PHARMACEUTICALS IN 3.37 1,264.44
EDWARDS LIFESCIENCES CORP 3.33 1,247.74
ABBVIE INC 2.91 1,091.80
INTUITIVE SURGICAL INC 2.87 1,074.74
GSK PLC 2.83 1,060.66

Stock Holding % of Net Assets

As Of 10/31/2025
Total Issues 85
Avg. P/E 26.19
Avg. P/Book 5.79
Avg. EPS Growth 14.85
Avg. Market Value (Mil $) 218,586

Composition

% of Portfolio
Stocks 97.12
Foreign Stocks 29.46
Cash 2.62
Bonds 0.00
Foreign Bonds 0.00
Preferred 0.00
Convertible 0.00
Other 0.26
Foreign Hedged 0.00

Style Analysis

% of Portfolio
Large Growth 0.00
Large Value 7.20
Small Growth 0.49
Small Value 0.00
Foreign Stock 4.36
Emerging Market 0.00
Precious Metal 0.04
Intermediate Bond 18.81
Foreign Bond 1.99
High Yield Bond 0.00